Please assess the completion status of the following clinical trial:

Trial Title: Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Women or adult men (\>18 years of age) with various medical diseases requiring long-term prednisolone treatment. Pre-menopausal women should have no plan for pregnancy within 2 years of study entry and agree to practice contraception during this 2-year period.~2. A daily dose of prednisolone (or equivalent) of more than 2.5mg within 3 months of study entry.~3. Having received oral bisphosphonate treatment for at least 2 years.~4. Suboptimal response to bisphosphonate treatment, defined as either one of the following: (1) failure of lumbar spine, femoral neck or total hip BMD values to increase; (2) values of lumbar spine, femoral neck or total hip BMD remain osteoporotic, ie. T scores \< -2.5 or Z scores \< -2.0; or (3) development of new fragility vertebral or non-vertebral fractures despite at least 2 years' treatment with good compliance.~5. Informed consent from patients.~Exclusion Criteria:~1. Patients with previous use of denosumab or teriparatide.~2. Premenopausal women who plan for pregnancy within 2 years of study entry or who do not agree for contraception within this 2-year period.~3. Patients with known bone disorders such as osteomalacia, renal osteodystrophy, and hyperparathyroidism.~4. Patients with unexplained hypocalcemia.~5. Patients with serum creatinine level of \>=200umol/L.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Denosumab (Type: ACTIVE_COMPARATOR): denosumab
- bisphosphonates (Type: ACTIVE_COMPARATOR): continuation of bisphosphonates

Based on this trial design, predict the completion outcome and termination type (if applicable).